ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Drug firm may have used tainted heparin

by Jean-François Tremblay
December 5, 2016 | APPEARED IN VOLUME 94, ISSUE 48

FDA has issued a warning to the Chinese drug ingredient manufacturer Dongying Tiandong Pharmaceuticals for failing to investigate results that showed some of its heparin may have been extracted from animals other than pigs. Shandong-based Dongying tested batches that showed its heparin may have been extracted from cattle, goats, sheep or other ruminants but didn’t investigate suppliers, FDA found. North American and European countries currently allow heparin only from pig sources. Heparin from sheep or goats has never been tested on humans.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment